# EDGAR Filing Document

**Accession Number:** 0001821080
**File Stem:** 0001580642-26-002036
**Filing Date:** 2026-3
**Character Count:** 13335
**Document Hash:** fa942ceed36a8213add0050c30067db0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001580642-26-002036.hdr.sgml**: 20260326

**ACCESSION NUMBER**: 0001580642-26-002036

**CONFORMED SUBMISSION TYPE**: N-8F

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260326

**DATE AS OF CHANGE**: 20260326

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Humankind Benefit Corp
- **CENTRAL INDEX KEY:** 0001821080

**ORGANIZATION NAME:**
- **EIN:** 852237195
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-8F
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23602
- **FILM NUMBER:** 26799569

**BUSINESS ADDRESS:**
- **STREET 1:** 79 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016
- **BUSINESS PHONE:** 646-838-4352

**MAIL ADDRESS:**
- **STREET 1:** 79 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Form N-8F**

**Application for Deregistration of Certain Registered Investment Companies.** 

**General Identifying Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Reason fund is applying to deregister (check *only one;* for descriptions, *see* Instruction 1 above):

[ ] **Merger**

[X] **Liquidation**

[ ] **Abandonment of Registration**

(Note: Abandonments of Registration answer *only* questions 1 through 15, 24 and 25 of this form and complete verification at the end of the form.)

[ ] **Election of status as a Business Development Company**

(Note: Business Development Companies answer *only* questions 1 through 10 of this form and complete verification at the end of the form.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Name of fund: **Humankind Benefit Corporation** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Securities and Exchange Commission File No.: **811-** **23602** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Is this an initial Form N-8F or an amendment to a previously filed Form N-8F? [X]
Initial Application [ ] Amendment

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. Address of Principal Executive Office (include No. & Street, City, State, Zip Code):

**Humankind Benefit Corporation**

**79 Madison Avenue**

**New York, NY 10016**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Name, address, and telephone number of individual
the Commission staff should contact with any questions regarding this form:

**Bernard Brick**

**Ultimus Fund Solutions, LLC**

**225 Pictoria Drive, Suite 450**

**Cincinnati, OH 45246**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(513) 346-4204**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. Name, address and telephone number of individual
or entity responsible for maintenance and preservation of fund records in accordance with rules 31a-1 and 31a-2 under the Act [17 CFR
270.31a-l, .31a-2]:

**Humankind Investments, LLC**

**79 Madison Avenue**

**New York, NY 10016**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(646) 838-4352**

**(records as investment advisor)**

**Ultimus Fund Solutions, LLC**

**225 Pictoria Drive, Suite 450**

**Cincinnati, OH 45246**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(513) 587-3400**

**(records as administrator)**

**Brown Brothers Harriman & Co.**

**140 Broadway**

**New York, NY 10005**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(617) 722-1818**

**(records as custodian and transfer agent)**

**Northern Lights Distributor, LLC**

**225 Pictoria Drive, Suite 450**

**Cincinnati, OH 45246**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(513) 587-3400**

**(records as distributor)**

Note*: Once deregistered, a fund is still required to maintain and preserve the records described in rules 31a-l and 31a-2 for the periods specified in those rules.*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. Classification of fund (check only one):

[X] Management company;

[ ] Unit investment trust; or

[ ] Face-amount certificate company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. Subclassification if the fund is a management company
(check only one):

[X] Open-end [ ] Closed-end

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. State law under which the fund was organized or
formed (*e.g.*, Delaware, Massachusetts):

**Maryland**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. Provide the name and address of each investment
adviser of the fund (including sub-advisers) during the last five years, even if the fund's contracts with those advisers have been
terminated:

**Humankind Investments, LLC**

**79 Madison Avenue**

**New York, NY 10016**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. Provide the name and address of each principal underwriter
of the fund during the last five years, even if the fund's contracts with those underwriters have been terminated:

**Northern Lights Distributor, LLC**

**225 Pictoria Drive, Suite 450**

**Cincinnati, OH 45246**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. If the fund is a unit investment trust ("UIT") provide: **N/A** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Depositor's name(s) and addressees):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Trustee's name(s) and address(es):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. Is there a UIT registered under the Act that served
as a vehicle for investment in the fund (*e.g.*, an insurance company separate account)?

[ ] Yes [X] No

If Yes, for each UIT state:

Name(s):

File No.: 811-<u> </u>

Business Address:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. (a) Did the fund obtain approval from the board of directors concerning the decision to engage in
 a Merger, Liquidation or Abandonment of Registration?

[X] Yes [ ] No

If Yes, state the date on which the board vote took place: **October 17, 2025**

If No, explain:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Did the fund obtain approval from the shareholders concerning the decision to engage in a Merger, Liquidation or Abandonment of Registration?

[ ]Yes [X] No

If Yes, state the date on which the shareholder vote took place:

If No, explain:

**The liquidation of the Humankind US Stock ETF, the sole series of Humankind Benefit Corporation, was not required to be approved by shareholders pursuant to the Humankind Benefit Corporation's Articles of Incorporation**.

&nbsp;&nbsp;&nbsp;&nbsp;**II.** **Distributions to Shareholders** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. Has the fund distributed any assets to its shareholders in connection with the Merger or

Liquidation?

[X] Yes [ ] No

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If Yes, list the date(s) on which the fund made those distributions: **December 8, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Were
the distributions made on the basis of net assets?

[X] Yes [ ] No

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Were the distributions made *pro rata* based on share ownership?

[X] Yes [ ] No

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If No to (b) or (c) above, describe the method of distributions to shareholders.
For Mergers, provide the exchange ratio(s) used and explain how it was calculated:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) *Liquidations only:* 

Were any distributions to shareholders made in kind?

[ ]Yes [X] No

If Yes, indicate the percentage of fund shares owned by affiliates, or any other affiliation of shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;17. *Closed-end funds only*: **N/A** 

Has the fund issued senior securities?

[ ]Yes [ ] No

If Yes, describe the method of calculating payments to senior securityholders and distributions to other shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;18. Has the fund distributed  ***all*** of its assets to the fund's shareholders? [X] Yes [ ] No

If No,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) How many shareholders does the fund have as of the date this form is filed? **N/A** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Describe the relationship of each remaining shareholder to the fund: **N/A** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. Are there any shareholders who have not yet received distributions in
complete liquidation of their interests?

[ ]Yes [X] No

If Yes, describe briefly the plans (if any) for distributing to, or preserving the interests of, those shareholders:

&nbsp;&nbsp;&nbsp;&nbsp;**III.** **Assets and Liabilities** 

&nbsp;&nbsp;&nbsp;&nbsp;20. Does the fund have any assets as of the date this form is filed?

*(See question 18 above)*

[ ]Yes [X] No

If Yes,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Describe the type and amount of each asset retained by the fund as of
the date this form is filed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Why has the fund retained the remaining assets?

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Will
the remaining assets be invested in securities?

&nbsp;&nbsp;&nbsp;&nbsp;21. Does the fund have any outstanding debts (other than face-amount certificates if the fund is a face-amount certificate company) or any other liabilities?

[ ]Yes [X] No

If Yes,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Describe the type and amount of each debt or other liability:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) How does the fund intend to pay these outstanding debts or other liabilities?

&nbsp;&nbsp;&nbsp;&nbsp;**IV.** **Information About Event(s) Leading to Request For Deregistration** 

&nbsp;&nbsp;&nbsp;&nbsp;22. (a) List the expenses incurred in connection with the Merger or Liquidation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Legal expenses: **$8,073.45** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Accounting expenses: **$14,057.80** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Other expenses (list and identify separately):

 **Tail Insurance: $50,400.00**

**Filing, printing and mailing: $1,159.01**

**Distributor related expenses: $1,524.37**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Total expenses (sum of lines (i)-(iii) above): **$75,214.63** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) How were those expenses allocated? **Humankind Investments, LLC paid all of the expenses described above.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Who paid those expenses? **Please see (b) above.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) How did the fund pay for unamortized expenses (if any)? **None** 

&nbsp;&nbsp;&nbsp;&nbsp;23. Has the fund previously filed an application for an order of the Commission
regarding the Merger or Liquidation?

[ ] Yes [X] No

If Yes, cite the release numbers of the Commission's notice and order or, if no notice or order has been issued, the file number and date the application was filed:

&nbsp;&nbsp;&nbsp;&nbsp;**V.** **Conclusion of Fund Business** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24. Is
the fund a party to any litigation or administrative proceeding?

[ ] Yes [X] No

If Yes, describe the nature of any litigation or proceeding and the position taken by the fund in that litigation: Is the fund now engaged, or intending to engage, in any business activities other than those necessary for winding up its affairs?

[ ] Yes [X] No

If Yes, describe the nature and extent of those activities:

&nbsp;&nbsp;&nbsp;&nbsp;**VI.** **Mergers Only** 

&nbsp;&nbsp;&nbsp;&nbsp;26. (a) State the name of the fund surviving the Merger:

**N/A**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) State the Investment Company Act file number of the fund surviving the Merger: 811-

**N/A**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) If the merger or reorganization agreement has been filed with the Commission, state the file number(s), form type used and date the agreement was filed:

**N/A**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If the merger or reorganization agreement has ***not*** been filed with the Commission, provide a copy of the agreement as an exhibit to this form.

**N/A**

**VERIFICATION**

The undersigned states that (i) he or she has executed this Form N-8F application for an order under section 8(f) of the Investment Company Act of 1940 on behalf of Humankind Benefit Corporation, (ii) he or she is the Secretary of Humankind Benefit Corporation, and (iii) all actions by shareholders, directors, and any other body necessary to authorize the undersigned to execute and file this Form N-8F application have been taken. The undersigned also states that the facts set forth in this Form N-8F application are true to the best of his or her knowledge, information, and belief.

<u>/s/ Bernard Brick</u> 

Name: Bernard Brick

Title: Secretary